A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 50 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and Above
Condition: Respiratory Syncytial Virus Infections Intervention: Biological: RSVPreF3 OA Investigational Vaccine Sponsor: GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 27, 2023 Category: Research Source Type: clinical trials
An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant
Condition: Lung Transplant; Complications Interventions: Other: Hybrid care arm; Other: Standard of care arm Sponsors: patientMpower Ltd.; University of Manchester; Manchester University NHS Foundation Trust; University College, London; New Start, The Wythenshawe Hospital Transplant Fund Centre Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 23, 2023 Category: Research Source Type: clinical trials
